WNT1-associated osteogenesis imperfecta with atrophic frontal lobes and arachnoid cysts

© 2019, The Author(s) under exclusive licence to The Japan Society of Human Genetics. A rare form of osteogenesis imperfecta (OI) caused by Wingless-type MMTV integration site family 1 (WNT1) mutations combines central nervous system (CNS) anomalies with the characteristic increased susceptibility t...

Full description

Saved in:
Bibliographic Details
Main Authors: Piranit Nik Kantaputra, Yuddhasert Sirirungruangsarn, Pannee Visrutaratna, Sasitorn Petcharunpaisan, Bruce M. Carlson, Worrachet Intachai, Jutamas Sudasna, Jatupol Kampuansai, Prapai Dejkhamron
Format: Journal
Published: 2019
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85060775236&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/63570
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Description
Summary:© 2019, The Author(s) under exclusive licence to The Japan Society of Human Genetics. A rare form of osteogenesis imperfecta (OI) caused by Wingless-type MMTV integration site family 1 (WNT1) mutations combines central nervous system (CNS) anomalies with the characteristic increased susceptibility to fractures. We report an additional case where arachnoid cysts extend the phenotype, and that also confirms the association of intellectual disabilities with asymmetric cerebellar hypoplasia here. Interestingly, if the cerebellum is normal in this disorder, intelligence is as well, analogous to an association with similar delays in a subset of patients with sporadic unilateral cerebellar hypoplasia. Those cases typically appear to represent vascular disruptions, and we suggest that most brain anomalies in WNT1-associated OI have vascular origins related to a role for WNT1 in CNS angiogenesis. This unusual combination of benign cerebellar findings with effects on higher functions in these two situations raises the possibility that WNT1 is involved in the pathogenesis of the associated sporadic cases as well. Finally, our patient reacted poorly to pamidronate, which appears ineffective with this form of OI, so that a lack of improvement is an indication for molecular testing that includes WNT1.